All Stories

Regulatory tracker: Keytruda picks up FDA priority revi...

In this tracker, Fierce Pharma is recording the regulatory progress of in-market...

In letter to RFK Jr., Democrats flag threats to drug re...

HHS secretary Robert F. Kennedy Jr. has been on the receiving end of two heated ...

India’s Granules makes $22M play for Senn Chemicals to ...

Granules shelled out a reported 20 million Swiss francs ($22.3 million) to acqui...

Lilly banks stockpile of oral GLP-1 drug with potential...

Looking to avoid a repeat of the shortages that plagued Mounjaro and Zepbound du...

Regulatory tracker: Gilead's twice-yearly PrEP injectio...

In this tracker, Fierce Pharma is recording the regulatory progress of in-market...

Eli Lilly, Novo Nordisk lead revenue boom in the 'alway...

Revenues in the biopharma industry continued to boom in the fourth quarter of la...

Eli Lilly, Novo Nordisk lead revenue boom in the 'alway...

Revenues in the biopharma industry continued to boom in the fourth quarter of la...

Beyond the Diagnosis: Embracing the Humanity Behind Epi...

Hear from UCB’s Brad Chapman on the importance of inclusion, representation, and...

After asset purchase from Travere, Mirum's Ctexli cross...

A little less than two years after San Francisco’s Mirum Pharmaceuticals ponied ...

Abbott's stigma-busting campaign shows how diabetes bia...

A new awareness campaign from Abbott highlights a major sticking point in diabet...

The power of patient communities: How patient communiti...

Patient communities on social are more than just support networks; they are livi...

Cosette sets sights on women's healthcare stardom with ...

The combined company will offer a diverse portfolio of women's healthcare pills ...

Once valued at $10B, bluebird bio sold to private equit...

Private equity firms Carlyle and SK Capital have agreed to pay $29 million to ac...

Novo Nordisk's semaglutide shortage officially conclude...

The FDA has officially declared an end to the supply squeeze on Novo Nordisk’s G...

Pfizer discontinues hemophilia treatment Beqvez, emptyi...

Pfizer is pulling further away from the gene therapy field with its decision to ...

PMCPA brings the buzzkill to LinkedIn celebration, layi...

The PMCPA has turned party pooper, coming down on GSK after learning that a U.K....

Regulatory tracker: Gilead's seladelpar nabs EU approva...

In this tracker, Fierce Pharma is recording the regulatory progress of in-market...

Fierce Pharma Asia—Novo Nordisk's fraud accusation; Ast...

Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading stateme...

A week after RFK Jr.'s confirmation, HHS postpones vacc...

Less than a week after newly confirmed HHS secretary Robert F. Kennedy Jr. quest...

Merck KGaA's EMD Serono taps Selma Blair to join long-r...

No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited actor Selma...

Canada locks down an initial 500K doses of GSK's bird f...

The Public Health Agency of Canada has leveraged an existing deal with GSK to lo...

Merck KGaA’s EMD Serono taps Selma Blair to join long-r...

No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited actor Selma...

Challenging powerhouse Pfizer, BridgeBio's launch of At...

BridgeBio reported that 1,028 unique prescriptions have been written by 516 diff...

Merck, plaintiff agree to hit the brakes on Gardasil tr...

Attorneys on the plaintiff's side, who are arguing that the vaccine caused injur...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.